Financhill
Back

Apellis Pharmaceuticals, Inc. Vs. CRISPR Therapeutics AG Industry Stock Comparison

Buy
56

APLS
Apellis Pharmaceuticals, Inc.

Last Price:
$25.23
Seasonality Move:
7.92%
Sell
46

CRSP
CRISPR Therapeutics AG

Last Price:
$56.69
Seasonality Move:
16.15%
Buy
56
Apellis Pharmaceuticals, Inc. (APLS) is a Buy

Is Apellis Pharmaceuticals, Inc. a Buy, Sell or Hold?

  • The current Apellis Pharmaceuticals, Inc. [APLS] share price is $25.23. The Score for APLS is 56, which is 12% above its historic median score of 50, and infers lower risk than normal.
  • APLS is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
46
CRISPR Therapeutics AG (CRSP) is a Sell

Is CRISPR Therapeutics AG a Buy, Sell or Hold?

  • The current CRISPR Therapeutics AG [CRSP] share price is $56.68. The Score for CRSP is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.
  • CRSP is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

APLS Stock Price Chart

What is Apellis Pharmaceuticals, Inc.'s stock price today?

  • The Apellis Pharmaceuticals, Inc. share price today is $25.23
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and APLS is experiencing buying pressure, which is a positive indicator for future bullish movement.

CRSP Stock Price Chart

What is CRISPR Therapeutics AG's stock price today?

  • The CRISPR Therapeutics AG share price today is $56.68
    The current trend is moderately bullish and CRSP is experiencing slight selling pressure.

APLS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.69 Buy
Relative Strength Index (14 RSI): 68.46 Buy
Chaikin Money Flow: 1409326 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (19.36 - 23.18) Buy
Bollinger Bands (100): (20.82 - 26.96) Buy

CRSP Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.18 Sell
Relative Strength Index (14 RSI): 50.79 Buy
Chaikin Money Flow: -310612 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (51.51 - 56.73) Buy
Bollinger Bands (100): (52.75 - 65.77) Sell

APLS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 23.69 Buy
20-day SMA: 21.71 Buy
50-day SMA: 23.11 Buy
200-day SMA: 21.92 Buy
8-day EMA: 23.84 Buy
20-day EMA: 22.66 Buy
50-day EMA: 22.73 Buy
200-day EMA: 24.25 Buy

CRSP Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 57.23 Sell
20-day SMA: 54.24 Buy
50-day SMA: 60.61 Sell
200-day SMA: 50.79 Buy
8-day EMA: 56.62 Buy
20-day EMA: 55.98 Buy
50-day EMA: 56.55 Buy
200-day EMA: 36.64 Buy

Apellis Pharmaceuticals, Inc. Earnings Growth & APLS Earnings Dates

  • Analysts estimate an earnings increase this quarter of $1.24 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.00 per share, and a decrease next year of $1.42 per share.

CRISPR Therapeutics AG Earnings Growth & CRSP Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.26 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.09 per share, and an increase next year of $1.74 per share.

Apellis Pharmaceuticals, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

CRISPR Therapeutics AG Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):